This statistic shows the reported operating profit of pharmaceutical company AstraZeneca from 2006 to 2023. AstraZeneca plc is one of the top 10 pharmaceutical companies worldwide (based on Rx drug revenue). The multinational company is headquartered in London, UK. AstraZeneca is focused on products for the following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. In 2023, the company reported an operating profit of some 8.2 billion U.S. dollars, the highest since 2011. Together with the Oxford University, the AstraZeneca also developed one of the first effective COVID-19 vaccines.
Operating profit of AstraZeneca from 2006 to 2024
(in million U.S. dollars)
Characteristic
Operating profit in million U.S. dollars
2024
10,003
2023
8,193
2022
3,757
2021
1,056
2020
5,162
2019
2,924
2018
3,387
2017
3,677
2016
4,902
2015
4,114
2014
2,137
2013
3,712
2012
8,148
02,5005,0007,50010,00012,50015,000
Add this content to your personal favorites. These can be accessed from the favorites menu in the main navigation.
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Learn more about how Statista can support your business.
AstraZeneca, & U.S. Securities and Exchange Commission. (February 17, 2025). Operating profit of AstraZeneca from 2006 to 2024 (in million U.S. dollars) [Graph]. In Statista. Retrieved March 13, 2025, from https://www.statista.com/statistics/266544/astrazeneca-operating-profit-since-2006/
AstraZeneca, und U.S. Securities and Exchange Commission. "Operating profit of AstraZeneca from 2006 to 2024 (in million U.S. dollars)." Chart. February 17, 2025. Statista. Accessed March 13, 2025. https://www.statista.com/statistics/266544/astrazeneca-operating-profit-since-2006/
AstraZeneca, U.S. Securities and Exchange Commission. (2025). Operating profit of AstraZeneca from 2006 to 2024 (in million U.S. dollars). Statista. Statista Inc.. Accessed: March 13, 2025. https://www.statista.com/statistics/266544/astrazeneca-operating-profit-since-2006/
AstraZeneca, and U.S. Securities and Exchange Commission. "Operating Profit of Astrazeneca from 2006 to 2024 (in Million U.S. Dollars)." Statista, Statista Inc., 17 Feb 2025, https://www.statista.com/statistics/266544/astrazeneca-operating-profit-since-2006/
AstraZeneca & U.S. Securities and Exchange Commission, Operating profit of AstraZeneca from 2006 to 2024 (in million U.S. dollars) Statista, https://www.statista.com/statistics/266544/astrazeneca-operating-profit-since-2006/ (last visited March 13, 2025)
Operating profit of AstraZeneca from 2006 to 2024 (in million U.S. dollars) [Graph], AstraZeneca, & U.S. Securities and Exchange Commission, February 17, 2025. [Online]. Available: https://www.statista.com/statistics/266544/astrazeneca-operating-profit-since-2006/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
